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A frequent empirical observation is that cold-induced 
counter-irritation may attenuate itch. The aim of this 
randomized, single-blinded, exploratory study was to 
evaluate the counter-irritation effects of cold-stimula-
tion and topical application of transient receptor po-
tential TRPA1/M8-agonists (trans-cinnamaldehyde/L-
menthol, respectively), on histamine-induced itch, 
wheals and neurogenic inflammation in 13 healthy vo-
lunteers. Histamine 1% was applied to the volar fore-
arms using skin prick-test lancets. Recorded outcome-
parameters were itch intensity, wheal reactions, and 
neurogenic inflammation (measured by laser-speckle 
perfusion-imaging). Homotopic thermal counter-irri-
tation was performed with 6 temperatures, ranging 
from 4°C to 37°C, using a 3 × 3-cm thermal stimulator. 
Chemical “cold-like” counter-irritation was conducted 
with 40% L-men thol and 10% trans-cinnamaldehyde, 
while 5% doxepin was used as a positive antipruritic 
control/comparator. Cold counter-irritation stimuli 
from 4°C to 22°C inhibited itch in a stimulus-intensity-
dependent manner (p < 0.05) and, to a lesser extent, 
also wheal reactions and neurogenic inflammation. 
Chemical “cold-like” counter-irritation with both L-
menthol and trans-cinnamaldehyde had antipruritic 
efficacy similar to doxepin (p < 0.05). Cold-induced 
counter-irritation had an inhibitory effect on histamin-
ergic itch, suggesting that agonists of cold transduc-
tion receptors could be of potential antipruritic value. 
Key words: itch; histamine; cold stimulation; TRPs; counter-
irritation; TRPM8; TRPA1.
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Itch is an unpleasant skin sensation that evokes scrat-ching and frequently manifests as a chronic distressing 
symptom in association with diseases such as urticaria, 
atopic dermatitis, psoriasis, and uraemia (1, 2). Chronic 
itch profoundly impacts on quality of life in affected 
patients and, due to a point prevalence of 8–13.5%, in 
combination with largely suboptimal treatments; itch 
represents a substantial socioeconomic burden (3–5). 
Itch is transmitted in 2 separate pruritic pathways with 
distinct primary afferent populations (6–9). A subdivi-
sion of pruriceptive mechano-insensitive C-fibres (CMi) 
convey histaminergic itch (induced in the present study), 
whereas a subdivision of pruriceptive polymodal C-fibres 
(PmC) transmit so-called non-histaminergic itch (10). 
The peripheral fibres synapse with central projections in 
the superficial layer of the spinal dorsal horn, from where 
the pruriceptive signals are transmitted to the thalamus 
and parabrachial nuclei (11–13). 
While scratching usually provides transient itch relief, 
it is thought to prolong exacerbations and be involved in 
chronification of itch by secondary mechanisms such as 
xerosis, inflammation, and infection, a phenomenon dub-
bed the vicious itch-scratch-itch cycle (14–16). However, 
the transient relief of itch achievable by introducing a 
mild painful or non-painful counter-irritation, such as 
scratching, a mechanism mediated by central segmental 
inhibition (17) via bhlhb5-interneurons in the spinal 
dorsal horn (18), signifies the existence of an effective 
endogenous mechanism capable of greatly attenuating 
itch. It has been shown experimentally that controlled 
thermal and mechanical painful stimuli inhibit itch and 
development of dysesthesias, such as alloknesis (10, 
15, 19–21). In addition, patients with itch frequently 
report that it is reduced by cold-stimulation (11, 22–25). 
This has led to the idea that counter-irritation with non-
painful/painful cooling or equivalent chemical agonists 
of cold thermosensory receptors, e.g. L-menthol, which 
is already in limited use, might be a feasible approach to 
alleviate chronic itch (12, 24). This approach is known 
from research into similar mechanisms related to pain-
processing, where counter-irritation has been widely 
studied (13, 26, 27). A frequently used counter-irritation 
modality is homotopically-applied cold, which is often 
effective in relieving inflammatory pain, a phenome-
non dubbed cold analgesia. However, evidence from 
psychophysical studies in patients with itch or using 
surrogate models of itch in healthy volunteers on the ef-
fect of cold or chemical “cold-like” counter-irritation is 
limited and contradictory (21, 24, 28, 29). For instance, 
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Bromm et al. (29) showed a strong antipruritic effect of 
mild non-noxious cooling and topical L-menthol, but 
aspects of these results were not reproduced in a later 
study with similar methodology (24, 30). The receptors 
conveying thermal sensations are known as transient re-
ceptor potential (TRP) channels and can be activated by a 
range of thermal and chemical stimuli (31–33). For cold 
thermosensation, TRPM8 is activated at ≤ 23–27°C and 
TRPA1 is activated at ≤ 15–17°C. Moreover, activation of 
TRPM8 and TRPA1 can be achieved by the use of their 
natural agonists L-menthol and trans-cinnamaldehyde 
(CA), respectively (27, 34–38), which provides an opp-
ortunity to study the potential gating of itch-signalling 
induced by homotopic cold counter-irritation using 
thermal and chemical stimuli comparatively. 
The aim of the present exploratory study was to quanti-
fy the dose-response relationship between homotopic 
cold stimulations or chemical “cold-like” stimulations 
and their counter-irritation effect on experimentally in-
duced histaminergic itch, wheals, and neurogenic inflam-
mation in healthy volunteers. The antihistamine doxepin 
(5%, topical pretreatment) was used as a comparator.
METHODS (for complete details see Appendix S11)
Test subjects and study design
Thirteen healthy subjects (mean age 22.8 ± 3 years; 8 males, 5 
females) participated in and completed the study after providing 
informed consent. The regional ethics committee of Northern 
Jutland approved the study protocol (N-20140078). All subjects 
participated in 2 90-min sessions with a minimum 24 h interval 
between sessions. The study was conducted in a randomized and 
single-blinded manner with the order of experimental interventions 
and arm dominancy randomized. Thus, histamine challenges and 
homotopic counter-irritation stimuli always alternated between 
the right and left arm. In total, 6 histaminergic itch provocations 
and 6 randomized counter-irritation stimuli (thermal/chemical) or 
control conditions were performed in each of the 2 experimental 
sessions (Fig. 1).
Thermal sensory thresholds, itch induction, itch assessment, and 
counter-stimulation
Prior to induction of itch in the first of the 2 experimental sessions, 
individual cold sensitivity was established using quantitative 
sensory testing (QST). The cold detection threshold (CDT) and 
cold pain threshold (CPT) were assessed with a baseline tempe-
rature of 32°C and ramp stimuli decreasing at a rate of 1°C/s. 
When the subjects pressed a button denoting CDT or CPT, the 
temperature returned to the baseline temperature at a rate of 5°C/s. 
Itch was induced using a solution of 1.0% histamine dihy-
drochloride (Allergopharma, Reinbek, Germany) and a standard 
shouldered 1-mm tip skin prick test (SPT) lancet. A drop of 
histamine solution was applied to the centre of a 3 × 3 cm square 
on the skin of the forearm and a custom-made SPT lancet-mount 
(Aalborg University, Denmark) delivered ≈ 200 g of pressure 
for 2–3 s (41). 
The subjects continuously expressed itch intensity on a 10-cm 
visual analogue scale (VAS0–10) after each itch provocation, with 
0 being labelled as “no itch” and 10 being labelled as “worst 
imaginable itch”. The VAS was sampled 4 times/min for the 
first 5 min of each application. Area under the curve (AUC) was 
calculated for the 0–2 min (before thermode-induced cold counter-
irritation) and at 2–5 min (during cold-counter stimulation). At 
3 or 5 min after each interventional condition, the subjects were 
asked to rate the mean pain experienced as a consequence of the 
counter-irritation on a VAS0–10, with 0 being “no pain” and 10 
“worst imaginable pain”. 
Thermal counter-irritation stimuli and thermal threshold assess-
ments of cold sensitivity (CDT and CPT) were conducted using 
the same 3 × 3-cm Thermal Stimulator probe attached to a Medoc 
Main Station (MMS). Thermal counter-irritation was applied at 6 
temperatures: 37, 32, 28, 22, 12, and 4°C. The counter-irritation 
was commenced 1 min and 55 s post-introduction of histamine 
and lasted for 3 min and 5 s.
Fig. 1. Overview of the experimental set-up of sessions 1 and 2. The illustration exemplifies the order of experimental procedures conducted in a 
single subject. Note that the actual order of thermal/chemical interventions was randomized under the condition that applications always switched from 
arm to arm. Green arrows: skin prick testing lancet application of histamine. Blue arrows: onset of the experimental thermal interventions. Wave shapes: 
temporal profiles of the itch intensity. L-menthol, CA, and doxepin were applied by pretreatment (see Methods). CA: trans-cinnamaldehyde, CDT: cold 
detection threshold; CPT: cold pain threshold; FLPI: full-field laser perfusion imaging; VAS: visual analogue scale.
1https://www.medicaljournals.se/acta/content/abstract/10.2340/00015555-2447
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Chemical counter-irritation was induced with 40% L-menthol 
(> 99.9%, TRPM8-agonist) and 10% CA (> 99%, TRPA1-agonist), 
(both Sigma Aldrich, Broendby, Denmark). These were dissolved 
in 96% ethanol and topically applied to the skin using a 3 × 3 cm 
cotton pad on a plastic sheet attached to the arm by medical tape. 
The substances were applied to the skin 7 min before itch induction 
to achieve a high level of counter-irritation during the applica-
tion period. Lastly, 5% doxepin (Region Hovedstadens Apotek, 
Copenhagen, Denmark) was applied to the skin under occlusion 
at least 60 min before the histamine application, as a comparator.
Neurogenic inflammation (superficial blood flow) and wheal 
reactions
To assess neurogenic inflammation, speckle contrast imaging 
(Moor FLPI, Moor Instruments, Axminister, UK) was recorded 
6 min after each histamine application. The imager was placed 
with a 50-cm distance to the application area, and the pictures 
were analysed with the appertaining proprietary software. Infra-
red thermography (A40, FLIR systems, Wilsonville, OR, USA) 
was conducted to ensure that the control condition of 32°C was 
within an appropriate temperature range, i.e. close to the normal 
physiological temperature of the subject. Wheals were measured 
horizontally and vertically 9 min after every application.
Statistical analysis
All statistical analyses were performed using SPSS version 22 
(IBM, New York, USA). The primary outcome was considered 
to be the intensity of itch 2–5 or 0–5 min after 1% histamine 
injections with/without counter-stimuli or control interventions 
and analysed with a repeated measures analysis of variance (RM-
ANOVA) test using the Sidak post hoc correction for multiple 
paired comparisons. Comparisons were made between experi-
mental interventions and their respective control; in particular, 
the thermal counter-stimuli were statistically compared with the 
32°C condition. Secondary outcome parameters were wheal and 
neurogenic inflammation, which were analysed similarly to the 
primary outcome. Tests were considered significant at p < 0.05, 
and highly significant at p < 0.01. All results are presented as the 
arithmetic means ± standard error of the mean (SEM).
RESULTS
The 13 healthy test subjects recruited for the experiment 
all completed both sessions of the study without expe-
riencing any adverse reactions during or after the study. 
Quantitative sensory thermal tests
The mean CDT was measured to 27.89 ± 1.05°C, i.e. 
very close to the least intense cold counter-irritation 
condition at 28°C, while the mean CPT was measured 
to 6.36 ± 1.87°C, and generally exhibited high inter-
individual variation.
Efficacy of counter-irritation
The temporal development of itch in response to 1% his-
tamine was highly reduced by the thermode-induced cold 
counter-irritation. Immediately after histamine injection, 
all test subjects rated rapidly increasing itch intensity, 
reaching a mean of 3.3 ± 1.2 (VAS0–10), immediately 
before application of cold-stimuli. Statistical analysis 
of the AUC after cold stimulation revealed significant 
reductions in itch intensity for all temperatures (p < 0.05 
or < 0.01), except for 32°C and 37°C, which both caused 
insignificant reductions in itch. VAS scores after the 
histamine application without interventions remained 
between 3.3 ± 1.1 and 3.8 ± 1.3, at 2 and 4 min, respecti-
vely (Fig. 2a). There were no significant differences in 
the comparison between itch intensity AUC from 0–2 
min post-histamine application (p > 0.6), indicating lack 
of bias between conditions. Inter-individual variation in 
the intensity of the histamine-provoked itch was high, 
i.e. the highest peak itch intensity score of the baseline 
condition was VAS = 8.2 and the lowest was VAS = 1.0. 
Similarly, all chemical counter-irritations, L-menthol 
(p ≤ 0.05), CA (p ≤ 0.01) and doxepin (p < 0.01) applied 
by pre-treatment, caused a significant and pronounced 
anti-pruritic effect in comparison with the baseline 
application of histamine (Fig. 2b). The anti-pruritic ef-
fect size of the chemical interventions varied between 
–48.5 ± 12.1% (for L-menthol) and –73.6 ± 10.4% (for 
CA), but no significant differences were found between 
effect sizes for any of the substances. 
When comparing thermode-induced cold counter-
irritation interventions with 32°C, adjusting for the me-
chanical pressure stimulation introduced by the weight 
of the probe, only cold stimulation at 22, 12, and 4°C 
caused significant decreases in itch intensity, signifying 
that both cold-stimuli in the innocuous and noxious range 
were sufficient to decrease histaminergic itch (see Fig. 
2c). Several of the applied counter-irritations gave rise 
to mild pain, with a mean VAS = 0.3 ± 0.2 for all inter-
ventions. CA resulted in a pain score of VAS = 1.7 ± 0.5, 
4°C resulted in 1.2 ± 0.3, and 12°C stimulation resulted 
in VAS = 0.5 ± 0.3. All other interventions were rated 
VAS ≤ 0.5. This is well aligned with the fact that CA, 
4°C, and 12°C also gave rise to the most profound anti-
pruritic effects.
Neurogenic inflammation (superficial blood perfusion) 
and wheals after histamine application
The mean skin temperature assessed by infrared ther-
mography prior to any tests was 32.67 ± 0.33°C, i.e. very 
close to the chosen control temperature of 32°C and with 
low inter-individual variability. The neurogenic inflam-
mation, also known as axon-reflex-flare was, for all ther-
mal conditions, most intense in the immediate injection 
area; 1–2 cm surrounding the injection site where a 3.2-
fold increase in superficial skin perfusion was observed, 
while the flare progressively normalized approximately 
4.0–4.5 cm away from the injection site. All thermal 
applications ≤ 28°C resulted in a significant decrease 
in skin perfusion compared with baseline, (p < 0.05), 
Fig. 3a, but only 22°C and 12°C stimuli reduced the 
H. H. Andersen et al.
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Fig. 2. Itch intensity rating on a visual analogue scale 
(VAS 0–10)during: (a) thermal cold-stimuli, and (b) chemical 
applications. (a) Dotted line: onset of counter-irritation. The 
graphs below depict the percentage of itch inhibition achieved 
by (c) thermal and (d) chemical counter-irritations calculated as 
the percentage reduction in itch area under the curve compared 
with the baseline histamine condition. Significance indication 
is based on comparison with the respective control conditions; 
32°C for (a) and (c), and control histamine for (b) and (d). 
Data are presented as arithmetic means ± standard error of 
the mean (SEM), *p < 0.05, **p < 0.01 and ***p < 0.001. CA: 
trans-cinnamaldehyde.
Fig. 3. Upper graphs depict the longitudinal 
dispersion of neurogenic inflammation in 
response to (a) thermal and (b) chemical experimental 
interventions compared with control conditions of 
histamine and (a) 32°C counter-irritation or (b) 
histamine alone. Lower graphs show the size of the 
wheal reactions, similarly in response to (c) each 
thermal and (d) chemical application and statistically 
compared with the control conditions of histamine 
and (c) 32°C counter-irritation or (d) histamine alone. 
Data are presented as arithmetic means ± standard 
error of the mean (SEM), *p < 0.05, **p < 0.01 and 
***p < 0.001.
Cold and cold-like inhibition of histaminergic itch 67
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neurogenic flare significantly compared with the 32°C 
control condition (p < 0.05). For the chemical counter-
irritation, the TRPA1-agonist CA expectedly resulted in 
a very large neurogenic inflammatory reaction (Fig. 3b), 
p < 0.001, as described previously (27, 36, 44). Doxepin 
and L-menthol both reduced the neurogenic inflamma-
tion by a moderate, but significant, extent (p < 0.05). The 
intensity and dispersion of the neurogenic inflammation 
assessed by speckle contrast imaging is shown in Figs 3a 
and b. Wheal reactions occurred under all experimental 
conditions, but were significantly decreased by thermal 
counter-irritation compared with the 32°C control condi-
tion (p < 0.01), with the exception of the 28°C stimulation 
(Fig. 3c). Both at 32°C and without any counter-irritation, 
the wheals were measured to 0.22 ± 0.01 cm2  on average. 
The decreases during thermal counter-irritation varied; 
from the lowest –0.06 ± 0.01 cm2 at 37°C, to the highest 
–0.20 ± 0.01 cm2 at 4°C, representing the almost total abo-
lition of the reaction. For the chemical counter-irritations, 
both 40% L-menthol (p < 0.05) and, to a much greater 
extent, 10% CA, and 5% doxepin (p < 0.001), reduced 
the wheal reactions (Fig. 3d). 
Correlational analyses
Correlational relationships were assessed between the 
magnitude of experienced anti-pruritic effect for any of 
the thermal or chemical counter-irritations and the QST 
parameters assessing individual cold hypersensitivity, 
i.e. CDT and CPT, as well as between the neurogenic 
flare and the itch intensity. There were no significant cor-
relations between these groups of parameters; however, 
a nearly significant positive association was found bet-
ween CPT and itch inhibition at 12°C (p = 0.061, n = 12), 
indicating that individuals exhibiting high cold pain 
sensitivity, i.e. high absolute CPT values, experienced 
more itch relief from cold counter-irritation near their 
pain threshold.
DISCUSSION
The present study investigated the inhibitory effect of 
homotopic, monophasic cold-stimuli, and TRP-agonist-
induced activity on histaminergic itch and vascular re-
sponses. For thermode-induced cold counter-irritation, 
a stimulus-response relationship was established for 
itch inhibition, starting at 22°C and increasing stepwise 
towards 4°C, while stimulation at 28°C and 37°C did 
not significantly inhibit histamine-induced itch percep-
tion compared with the control condition at 32°C. The 
chemical counter-irritations resulted in significant itch 
inhibition, the most effective being 10% CA followed 
by 40% L-menthol. The 5% topical doxepin applied as 
antipruritic control and comparator gave rise to inhibi-
tion of itch at a magnitude similar to 10% CA and 40% 
L-menthol. Listed in order of highest antipruritic effect 
the counter-irritations: 4°C, 12°C, 10% CA, 22°C, 40% 
L-menthol, as well as the positive control, 5% doxepin, 
all gave rise to a total reduction in itch of more than 40% 
compared with respective control conditions. In addi-
tion, stimuli with 22°C, 12°C, but not 4°C, in addition 
to doxepin and L-menthol reduced the local neurogenic 
inflammatory histamine-evoked response. 
Antipruritic effect of thermode-evoked cold and cold-
like chemical stimulations
Few studies have attempted to assess or quantify the 
antipruritic effect of cold stimulation at different tempe-
ratures or chemical “cold-like” stimulation, despite the 
fact that cold-induced alleviation of itch is commonly 
reported in patients (4, 45). While it has frequently 
been observed that painful cold (or heat) stimulation 
results in inhibition of itch (46–48), the effect of non-
painful thermode-induced cold counter-irritation or TRP-
modulation by, for example, L-menthol, is less clear. 
Bromm et al. (29) found a significant decrease mediated 
by 1% L-menthol on histamine-induced itch; however, 
this finding was not reproduced in a subsequent study 
despite a 10-fold increase in L-menthol concentration. 
Similarly, studies have reported that both homotopic and 
heterotopic (in the same dermatome) innocuous cold-
stimuli significantly attenuate histaminergic itch (21, 
29), while 2 other studies, applying similar methodology, 
have reported that itch is aggravated by innocuous cold 
stimulations at 25°C (28, 30). The present data supports 
the prevailing notion that homotopic innocuous cold is 
sufficient to significantly reduce experimentally evoked 
itch. While cold analgesia of cutaneous and deep tissue 
pain is thought to rely on a combination of anti-nocicep-
tive gating, decreased nerve conductivity, and diminished 
oedema, the antipruritic effect of cold-stimulation is 
probably less multifactorial. Since L-menthol does not 
change the actual temperature of the skin (required to 
affect neuronal conductivity), but decreases itch by a 
magnitude similar to thermal stimuli at 22°C and 12°C, 
it is likely that lateral inhibition from cold-encoding 
Aδ-fibres is the primary mechanism behind the observed 
antipruritic effect. This proposition is also well supported 
by the fact that antipruritic efficacy slightly weaker than 
presented here has been observed when applying the 
thermal counter-stimulation 3-cm distally to the site of 
itch induction, hereby assuring limited interference from 
potential local inhibitory mechanisms (21). 
In the present study, counter-irritation with 4°C and 
10% CA were both found to evoke mild pain during 
the application period; an effect likely to be mediated 
by counter-irritancy through TRPA1-positive cold C-
nociceptors (36, 49, 50). This is well in line with previous 
studies on the effect of painful counter-irritation of expe-
rimentally induced itch, wherein particularly painful me-
chanical stimuli (i.e. controlled scratching) and noxious 
H. H. Andersen et al.
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heat stimuli have been shown to significantly reduce itch 
(15, 20, 21). The mean of the observed CDT was on par 
with previously reported data for healthy controls (27, 
40), while the mean CPT at 6.4°C was slightly below the 
usual reports of 10–13°C (27, 40). This is probably a con-
sequence of CPT being a QST measure characterized by 
very high inter-individual variability (40) in combination 
with a relatively small sample size. A tendency towards 
a positive correlation was found between CPT and itch 
inhibition at 12°C (p = 0.061), indicating that individuals 
with high cold pain sensitivity, might be more susceptible 
to effective cold-induced itch relief. 
Vasomotor manifestations of thermode-evoked cold 
and cold-like stimulations
For the thermal stimulations, a significant inhibitory 
effect on the neurogenic inflammatory response to his-
tamine was found for stimulation at 22°C and 12°C, 
but not 4°C. Cutaneous cold-stimuli are well known to 
cause local vasoconstriction and, if sufficiently strong 
and persistent, subsequent transient paradoxical va-
sodilation after 3–4 min of stimulation. This, and the 
short delay between removal of the thermal probe and 
laser speckle contrast image recordings, could explain 
why cold-stimuli below the painful threshold (22°C 
and 12°C) appear to inhibit neurogenic inflammation, 
while stimulation above the pain threshold at 4°C, did 
not cause a significant decrease in neurogenic inflamma-
tion. In addition, painful cold stimulation is thought to 
entail TRPA1 activation, although this remains disputed 
(51), and TRPA1 exhibits co-expression with TRPV1 on 
peptidergic nociceptive C-fibres capable of generating 
axon-reflex flare (52, 53). This means that the paradoxi-
cal lack of inhibition of neurogenic inflammation at 4°C 
could be a consequence of responses being masked by ad-
ditional recruitment of nociceptive C-units, beyond those 
CMi-fibres activated by histamine-introduction. Thermal 
stimulations ≤ 22°C stimulus-intensity-dependently de-
creased wheal reactions compared with the 32°C control 
condition. Wheal reactivity has not previously been as-
sessed for a range of cold stimulations. Mechanistically, 
the observed vasoconstriction is probably mediated by 
a direct cold-induced smooth muscle contraction in the 
most superficial dermal capillaries (54). 
As shown previously, the applied control, doxepin, 
drastically reduced neurogenic inflammation and wheal 
reactions, conceivably by direct inhibition of H1R on 
CMi-fibres (6, 43, 55, 56). L-menthol was also observed 
to reduce neurogenic inflammation and wheal formation, 
probably either via TRPM8-induced capillary constric-
tion (57–59) or via potential TRPV1-cross-desensiti-
zation (60–63), given that TRPV1 is highly involved 
in downstream processing of histaminergic signalling 
(64). Interestingly, topical L-menthol, occasionally in 
much lower concentrations (above or equal to 1%), has 
previously been found to reduce histaminergic and CA-
induced neurogenic flare (27, 29); however, contradictory 
evidence does exist (24). The concentration of 10% CA 
used in the current study induced a stronger neurogenic 
inflammatory response than histamine, through direct 
activation of TRPA1-positive nociceptors (36, 65). On 
the other hand, CA profoundly reduced wheal formation 
and, in fact, abolished wheal formation completely in 5 
subjects. The wheal reaction is based on localized dermal 
protein extravasation and is likely to wane when the app-
lied histamine and extravasation products are sufficiently 
diluted by cutaneous blood perfusion (8). This process 
was conceivably augmented by the 5-fold increase in 
superficial blood perfusion induced by CA pre-treatment 
and a similar mechanism could be relevant for the slight, 
but significant, decrease in wheal size observed at 37°C. 
Study limitations 
High concentrations of topically applied ethanol are 
suspected to entail minor somatosensory, but not neu-
rogenic, inflammatory changes, although previously 
published results are conflicting (27, 36, 66) and the 
supposed mechanism is unclear (67). The present study 
did not include a vehicle condition for application of the 
chemical substances, for the following reasons: (i) even 
in the few studies that do find somatosensory changes 
following ethanol application, the effect is very subtle 
(36, 68); (ii) there is no spontaneous sensation associated 
with ethanol when applied as in the present study (12, 
68); and (iii) a previous study failed to find any effect of 
80% ethanol on histaminergic itch (24). Nonetheless, it 
cannot be excluded that topical ethanol and the vehicle 
cream for application of doxepin have minor antipruritic 
effects, especially since ethanol is a TRPV1 agonist (69). 
Similarly, although the 32°C stimulation was chosen 
because it is known to be an approximation of the physio-
logically normal skin temperature, a significant decrease 
in itch was observed compared with histamine application 
without thermal counter-irritation, presumably due to the 
ongoing mechanical counter-stimulus from the thermal 
stimulator probe. Ideally, cold counter-irritation should 
be applied without concomitant activation of mechano-
receptive Aβ-fibres, but this remains a technological chal-
lenge. CA produced spontaneous burning/pricking pain 
and extensive neurogenic inflammation in a number of 
subjects, which is known to drastically reduce homotopic 
itch. Future studies should include a titration of CA to a 
concentration at which it provides somatosensory counter-
irritation without provoking spontaneous pain and neu-
rogenic inflammation. In this context, it is a concern that 
lower concentrations of topical CA alone have previously 
been shown to have pruritogenic effects in humans (12). It 
should be kept in mind that itch and pain sensations were 
not quantified similarly in the present study; while itch 
was scored continuously as it occurred, subjects had to 
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recall the pain intensity of the previously applied counter-
irritation stimuli, immediately after the stimuli had ended. 
As a result, comparisons can be made within the resulting 
itch and pain scores, but not across the sensory modalities. 
Lastly, the present study applied a histaminergic human 
surrogate model of itch conveyed by a subset of pruricep-
tive CMi-fibres. Future studies should ascertain whether 
itch induced by a non-histaminergic model, such as the 
mucunain-model (cowhage) (8, 12), and thus activating 
PmC-fibres, also known to transmit pain under certain 
circumstances (70), would be susceptible to effective 
cold-induced itch suppression.
Conclusion
The thermal cold-stimuli applied in this study inhibited 
histaminergic itch in a stimulus-intensity-dependent 
manner of which the painful thermode-provoked sti-
mulations had the highest antipruritic effect. A similar 
inhibitory tendency was observed on wheal reactions 
and neurogenic inflammation. In addition, the applied 
chemical proxies of cold-stimuli, L-menthol and trans-
cinnamaldehyde, had significant inhibitory effects on 
histaminergic itch with an antipruritic effect-size com-
parable to that of 5% topical doxepin. Thermal counter-
stimuli or selective and potent TRPA1-/TRPM8-agonists, 
titrated to concentrations evoking counter-irritation at 
sub-pain threshold levels could be potential antipruritic 
treatment modalities, particularly for those chronic itch 
patients reporting itch alleviation by cooling.
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